MOOLEC SCIENCE SA Increase Decrease In Cash And Cash Equivalents
MOOLEC SCIENCE SA (MLEC) reported Increase Decrease In Cash And Cash Equivalents of -$3.45 million for the 6-month period ending 2024-12-31, per its 6-K filed 2025-04-16.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents · last filed 2025-04-16
- MOOLEC SCIENCE SA increase decrease in cash and cash equivalents for the quarter ending 2023-12-31 was $787.57K, a 91.57% decline year-over-year.
- MOOLEC SCIENCE SA increase decrease in cash and cash equivalents for the quarter ending 2023-09-30 was -$1.70M, a 17683.37% decline year-over-year.
- MOOLEC SCIENCE SA increase decrease in cash and cash equivalents for the quarter ending 2023-06-30 was -$3.57M.
- MOOLEC SCIENCE SA increase decrease in cash and cash equivalents for the quarter ending 2023-03-31 was -$4.35M, a 509.73% decline year-over-year.
| Period end | Increase Decrease In Cash And Cash Equivalents 3 month | Increase Decrease In Cash And Cash Equivalents 6 month | Increase Decrease In Cash And Cash Equivalents 9 month | Increase Decrease In Cash And Cash Equivalents 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$3.45M 6-K · filed 2025-04-16 | |||
| 2024-06-30 | $2.52M 20-F · filed 2024-10-30 | |||
| 2023-12-31 | $787.57K derived: 6-K 6 month − 6-K 3 month · filed 2025-04-16 | -$908.88K 6-K · filed 2025-04-16 | -$4.48M derived: sum of 3 quarters · filed 2025-04-16 | -$8.83M derived: sum of 4 quarters · filed 2025-04-16 |
| 2023-09-30 | -$1.70M 6-K · filed 2024-01-22 | -$5.27M derived: sum of 2 quarters · filed 2024-10-30 | -$9.61M derived: sum of 3 quarters · filed 2024-10-30 | -$272.60K derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | -$3.57M derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | -$7.92M derived: sum of 2 quarters · filed 2024-10-30 | $1.42M derived: sum of 3 quarters · filed 2024-10-30 | $1.43M 20-F · filed 2024-10-30 |
| 2023-03-31 | -$4.35M derived: 6-K 9 month − 6-K 6 month · filed 2023-07-10 | $4.99M derived: sum of 2 quarters · filed 2023-07-10 | $5.00M 6-K · filed 2023-07-10 | $4.90M derived: sum of 4 quarters · filed 2024-10-30 |
| 2022-12-31 | $9.34M derived: 6-K 6 month − 6-K 3 month · filed 2023-04-03 | $9.35M 6-K · filed 2023-04-03 | $9.24M derived: sum of 3 quarters · filed 2024-10-30 | $10.30M derived: sum of 4 quarters · filed 2024-10-30 |
| 2022-09-30 | $9.65K 6-K · filed 2024-01-22 | -$99.26K derived: sum of 2 quarters · filed 2024-10-30 | $961.45K derived: sum of 3 quarters · filed 2024-10-30 | |
| 2022-06-30 | -$108.91K derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $951.81K derived: sum of 2 quarters · filed 2024-10-30 | $114.02K 20-F · filed 2024-10-30 | |
| 2022-03-31 | $1.06M derived: 6-K 9 month − 6-K 6 month · filed 2023-07-10 | $222.93K 6-K · filed 2023-07-10 | ||
| 2021-12-31 | -$837.78K 6-K · filed 2023-04-03 | |||
| 2021-06-30 | $980.53K 20-F/A · filed 2023-11-02 |